Degenerative Joint Disease of the Ankle Clinical Trial
Official title:
A Pilot Study to Evaluate the Contribution of the Saphenous Nerve in Ankle Pain of Patients With Degenerative Joint Disease of the Ankle
NCT number | NCT01716650 |
Other study ID # | 09-007710 |
Secondary ID | |
Status | Terminated |
Phase | |
First received | |
Last updated | |
Start date | October 2012 |
Est. completion date | September 2016 |
Verified date | December 2017 |
Source | Mayo Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To assess the pain scores before and after saphenous nerve block placement in patients with degenerative joint disease of the ankle
Status | Terminated |
Enrollment | 4 |
Est. completion date | September 2016 |
Est. primary completion date | September 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility |
Inclusion Criteria: - Patients evaluated with osteoarthritis who are surgical candidates for ankle fusion or total ankle replacement. - Registered patients at Mayo Clinic in Florida with scheduled visit to see Dr.Whalen Exclusion Criteria: - Patients with lower extremity diabetic neuropathy - History of prior trauma of ankle with residual nerve injury - Current medication of pregabalin or gabalin - Allergy to lidocaine. |
Country | Name | City | State |
---|---|---|---|
United States | Mayo Clinic | Jacksonville | Florida |
Lead Sponsor | Collaborator |
---|---|
Mayo Clinic |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Ankle pain | Patient's ankle pain will be assessed prior to and after the nerve block. The study will assess if pain score is lower after the saphenous nerve block | 30 minutes |